OPNT

Opiant Pharmaceuticals, Inc. Common Stock
OPNT

Overview Fund Activity
Delisted

OPNT was delisted on the 1st of March, 2023.

Back to rankings

26 hedge funds and large institutions have $11.7M invested in Opiant Pharmaceuticals, Inc. Common Stock in 2018 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 8 increasing their positions, 3 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
26
Holders Change
+10
Holders Change %
+62.5%
% of All Funds
0.6%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
8
Reduced
3
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
SCM
Stonepine Capital Management
Oregon
$3.32M
2
GPCM
Granite Point Capital Management
Massachusetts
$1.34M
3
HI
HBK Investments
Texas
$1.07M
4
CLCM
Crawford Lake Capital Management
New Jersey
$841K
5
SM
Sabby Management
Florida
$781K

Top Sellers

1
Acadian Asset Management
Acadian Asset Management
Massachusetts
$44K
2
OSAM
O'Shaughnessy Asset Management
Connecticut
$60K
3
RA
Royce & Associates
New York
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
RA
26
Royce & Associates
New York
– -$6K -431 Closed
1
2